Cookies

Like most websites The Pathologist uses cookies. In order to deliver a personalized, responsive service and to improve the site, we remember and store information about how you use it. Learn more.

Precision medicine

Subspecialties Oncology

EGFR Exon 20 Insertion: A New Player in the NSCLC Landscape

| Sponsored by Thermo Fisher Scientific

How to choose the right biomarker test for success in precision oncology

Diagnostics Precision medicine

Blood-Based Biopsy for Cancer-Predisposed Patients

| Michael Schubert

A new liquid biopsy test can allow easier, more accurate diagnosis of malignancy in patients who are predisposed to cancer

Diagnostics Oncology

Working Together Works

| Sponsored by Thermo Fisher Scientific

An expert panel discusses current progress and future possibilities to collaborate in the field of targeted therapy in lung cancer

Diagnostics Genetics and epigenetics

Next-Generation Sequencing: The Next Microscope

| Brandon S. Sheffield

Brandon S. Sheffield shares his experience with onboarding in-house NGS testing – and why he thinks everyone should follow suit

Subspecialties Bioinformatics

RNA: The Villain… and the Hero

| Jarret Glasscock

Big data is key to precision medicine, but presents a stumbling block for analysis – can machine learning help us overcome this hurdle?

Diagnostics Genetics and epigenetics

Rethinking Risk Stratification for Acute Lymphoblastic Leukemia

| Olivia Gaskill

Integrated pediatric leukemia risk stratification and relapse prediction

Subspecialties Oncology

Fostering Collaboration and Sharing Know-How in Precision Medicine

| Sponsored by Thermo Fisher Scientific

Umberto Malapelle discusses his lab’s experience with onboarding precision medicine – and how other laboratories can follow in their footsteps

Diagnostics Genetics and epigenetics

KRAS G12C: The Mutation You Thought You Knew

| Sponsored by Amgen Oncology

Six reasons the KRAS G12C mutation matters

Inside the Lab Precision medicine

Personalized medicine – in vitro drug testing on primary cancer cells

| Sponsored by Tecan

Personalized treatments have the greatest potential to benefit cancer patients.

Subspecialties Clinical care

Educational e-book: Dive into hematology and hematopathology!

Discover the intricacies of the hematopoietic system and its disorders


Latest Application Notes

All Application Notes

Sister Publications

You might be interested in our Sister Publications:

Register to The Pathologist

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Pathologist magazine

Register